Catherine Coste is Director of BIOMERICA INC. Currently has a direct ownership of 43,790 shares of BMRA, which is worth approximately $16,202. The most recent transaction as insider was on Jan 26, 2023, when has been sold 2,190 shares (Common Stock) at a price of $2.96 per share, resulting in proceeds of $6,482. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.8K
0% 3M change
0% 12M change
Total Value Held $16,202

Catherine Coste Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2023
BUY
Open market or private purchase
$6,482 $2.96 p/Share
2,190 Added 4.76%
43,790 Common Stock

Also insider at

RNLX
Renalytix plc Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
CC

Catherine Coste

Director
Irvine, CA

Track Institutional and Insider Activities on BMRA

Follow BIOMERICA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRA shares.

Notify only if

Insider Trading

Get notified when an Biomerica Inc insider buys or sells BMRA shares.

Notify only if

News

Receive news related to BIOMERICA INC

Track Activities on BMRA